Stay updated on Combination Immunotherapy in SCLC Clinical Trial
Sign up to get notified when there's something new on the Combination Immunotherapy in SCLC Clinical Trial page.

Latest updates to the Combination Immunotherapy in SCLC Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedA dedicated Locations section was added, listing Florida as a study site. This updates where the trial is conducted and available for enrollment.SummaryDifference0.2%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check30 days agoChange DetectedPage revision updated from v3.3.1 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check37 days agoChange DetectedAdministrative page revision updated from v3.2.0 to v3.3.1; this change does not alter study content, eligibility criteria, outcomes, or user-facing functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check44 days agoChange DetectedAdded sections listing the Moffitt Cancer Center Clinical Trials website, the H. Lee Moffitt Cancer Center and Research Institute, and a 'Helpful Links Provided by' area. Removed the government funding status notice regarding NIH/agency operating status.SummaryDifference0.5%

- Check58 days agoChange DetectedMinor layout and formatting updates to the study page; core data such as eligibility, outcomes, and enrollment appear unchanged.SummaryDifference0.4%

- Check87 days agoChange DetectedBig update: new operating status notice and version v3.2.0 added; a specific resource (Small cell lung carcinoma) and older version v3.1.0 removed.SummaryDifference3%

Stay in the know with updates to Combination Immunotherapy in SCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Combination Immunotherapy in SCLC Clinical Trial page.